The Recall Desk
CriticalFDA (Devices)·Z-2702-2017·Announced 2017-07-26

Penumbra 3D Revascularization Device Recalled Due to Delivery Wire Breakage Risk

Penumbra Inc. is recalling 155 units of the 3D Revascularization Device because a raw material issue could cause the delivery wire to break, potentially leading to serious injury or death.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The source text explicitly states that the defect could potentially lead to serious patient injury or death, which meets the criteria for a Critical severity score (5) under the rubric.

Plain-English summary

Penumbra Inc. is recalling 155 units of the Penumbra 3D Revascularization Device. The device is indicated for the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease within 8 hours of symptom onset. The recall affects lots C00644, C00645, C00646, and C00717.

The recall was initiated because Penumbra identified an issue in these four lots involving a raw material component of the delivery wire. This issue could result in breakage of the delivery wire, which could potentially lead to serious patient injury or death.

The affected units were distributed nationwide to the following states: AZ, CA, CO, FL, IN, MA, MI, MN, NV, NY, OH, OK, PA, SC, TN, TX, UT, VA, and WV. Healthcare providers and facilities should stop using the affected devices and contact Penumbra Inc. for further instructions.

The recalled product

Product
Penumbra 3D Revascularization Device It is indicated for used in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral-M1 and M2 segments) within 8 hours of symptom onse
Manufacturer
Penumbra Inc.
Affected units
155

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • Lots C00644
  • C00645
  • C00646
  • C00717

Distribution

Distributed nationwide across the United States.

The notice also names 19 states specifically: